Riskpilot← Back to searchSign inGet full accessHälsobemanning i Stockholm AB
ABActiveOrg 5567597926Primusgatan 51General medical practice activities · NACE 8621Est. 20081 employees
Revenue 2025
SEK 93K
-66% vs 2024
EBITDA margin
-348.3%
-283% vs 2024
Equity ratio
49.7%
Financial strength
Net profit 2025
SEK -315K
-300% vs 2024
| Revenue | SEK 93K | -66% |
| EBITDA | SEK -323K | -283% |
| Net profit | SEK -315K | -300% |
| Total assets | SEK 275K | -58% |
| Equity | SEK 136K | -70% |
| Employees | 1 | — |
Legal name
Hälsobemanning i Stockholm AB
Org number
5567597926
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 juni 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva bemanningsföretag med inriktning inom vården samt därmed förenlig verksamhet. Bolaget skall även bedriva hemtjänstverksamhet. Bolaget kommer även att bedriva en webbyrå med delarna webbdesign, digital design, grafisk design, digital kommunikation samt fotografisk verksamhet.
Address
Primusgatan 51
Phone
+46843742609
Email
info@halsobemanning.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 269 | 627 | 398 | 277 | 93 |
| Staff expenses | — | −9 | −3 | −85 | −30 |
| EBITDA | 72 | 409 | 120 | −84 | −323 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 72 | 409 | 120 | −84 | −323 |
| Net financials | −1 | −0 | 0 | 5 | 8 |
| Profit before tax | 71 | 409 | 121 | −79 | −315 |
| Tax | −13 | −84 | −25 | — | — |
| Net profit | 58 | 325 | 96 | −79 | −315 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 391 | 887 | 854 | 661 | 275 |
| Equity | 310 | 635 | 731 | 452 | 136 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 81 | 253 | 123 | 209 | 138 |
| Total debt | 81 | 253 | 123 | 209 | 138 |
EBITDA margin
-348.3%
This company
15.8%
Market median
-2304% vs market
20212025
Equity ratio
49.7%
This company
38.2%
Market median
+30% vs market
20212025
Return on equity
-231.4%
This company
18.4%
Market median
-1358% vs market
20212025
Net profit margin
-340.1%
This company
8.1%
Market median
-4299% vs market
20212025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20212025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NA Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
KS Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsobemanning i Stockholm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Stefan Mattsson | Audit | 0 companies |
| Nicklas Ahmad Nasseri | Chief Executive Officer | 0 companies |
| Leo Shervin Nasseri | Deputy Board Member | 0 companies |
| Morteza Mathias Nasseri | Deputy Board Member | 0 companies |